21-Jul-2010 - Reaxa has received a UK Technology Strategy Board (TSB) award to further development of cleaner catalysts for pharmaceutical manufacturing.
20-Jul-2010 - Emergent BioSolutions says additional biomanufacturing space at its Baltimore, Maryland plant could help reduce expenditure through use of new timesaving manufacturing tech.
19-Jul-2010 - Germany’s Merck KGaA has completed its $7bn (€b5.2n) acquisition of Millipore, unveiling plans to target “high-growth, high-margin” bio-research and bio-production markets.
15-Jul-2010 - ATMI Lifesciences has introduced 2D and 3D single-use bioprocess vessels (BPV) which reduce risk and cut costs.
13-Jul-2010 - Research has been initiated into the prediction of process performance before scale up to help increase yield and efficiency while cutting costs.
12-Jul-2010 - A new study believes vaccine manufacturers from developing countries may be able to produce a HPV vaccine at a lower cost without infringing on the numerous patents drug makers have taken out on the vaccine technology.
08-Jul-2010 - Millipore is targeting protein manufacturers with a new chromatography resin that, the firm claims, offers flexibility and high throughput with a small manufacturing footprint.
05-Jul-2010 - Converters and manufacturers will be able to measure the real-life performance of packaging barrier products with greater speed and accuracy thanks to an enhanced water vapour transmission rate (WVTR) instrument, said Mocon Inc.
05-Jul-2010 - GlaxoSmithKline (GSK) and the Singapore EDB are to fund eight research projects into green and sustainable production of pharmaceuticals and fine chemicals.
29-Jun-2010 - Results from PAT humidity monitoring research will improve API granulation process, product yields and reduce variability during drug manufacture, says NextPharma.
24-Jun-2010 - A new technique developed by researchers has yielded results, which suggests that drug production and manufacturing can essentially be achieved without toxic by-products.
23-Jun-2010 - US supplier SAFC recently expanded its liquid cell culture reagents in response to growing biomanufacturing industry demand.
15-Jun-2010 - Pall and New Brunswick have teamed up to develop and supply new disposable bioreactor technologies, targeting growing demand for products that improve quality and reduce cost of biomanufacturing.
10-Jun-2010 - Xcellerex is building a second cGMP FlexFactory biomanufacturing facility to support clients transitioning to their own plants and provide contract manufacturing services.
02-Jun-2010 - ISP Pharmaceuticals has expanded its extrusion spheronisation offering with the installation of new dedicated technology at its laboratory in Sao Paulo, Brazil.
31-May-2010 - Researchers have developed an alternative, cheaper method of producing insulin to help increase availability in emerging markets.
20-May-2010 - in-PharmaTechnologist visualises the depth and distribution of the cuts Pfizer plans to make to its global manufacturing network.
20-May-2010 - Eisai has opened a $100m (€81m), 65,000 sq ft commercial manufacturing and drug development site for intravenous treatments in Research Triangle Park (RTP), North Carolina, US.
19-May-2010 - Pfizer plans to close eight manufacturing sites and reduce operations at a further six by the end of 2015, leading to 6,000 job losses, as part of its reorganisation after acquiring Wyeth.
18-May-2010 - Xcellerex’ development and bioprocess manufacturing technology plays key role in creation of rapid, low-cost vaccine production system.
12-May-2010 - Microfluidics has posted an operating income of $106,000 (€84,000) in its results, the third consecutive quarter of profit, and is looking to expand products and services to continue growth.
12-May-2010 - Beike Biotechnology has opened a stem cell storage and processing facility at the 20,000 sq m regenerative medicine base in China, furthering the nation’s development in the field.
11-May-2010 - DSM Biologics says successful XD tech expansion paves way for smaller bioreactors that lowers cost of production facilities and, ultimately, of bio-drug manufacture.
10-May-2010 - Millipore says that rebounding Big Pharma spending and biotechnology drove first-quarter 2010 gains.
05-May-2010 - DSM Biologics says combining its XD platform with newly-acquired Rhobust chromatography platform will create high yield, low cost bio-manufacturing option.